Cu-64 TP3805
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Cu-64 TP3805, covering 2018-01-09 to 2025-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy [EARLY_Phase 1]